Child-parent immunization survey: How well are national immunization recommendations accepted by the target groups?
Cocooning
Immunization
Influenza
Pertussis
Pregnancy
Journal
Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769
Informations de publication
Date de publication:
11 Apr 2019
11 Apr 2019
Historique:
received:
08
08
2018
revised:
05
01
2019
accepted:
06
02
2019
entrez:
7
8
2019
pubmed:
7
8
2019
medline:
7
8
2019
Statut:
epublish
Résumé
Pertussis disease rates are high in Switzerland, especially in infants and young infants. To protect newborns from this serious disease, EKIF, the Swiss National Immunization Technical Advisory Group, has recommended vaccination against pertussis during pregnancy (2nd or 3rd trimester) since 2013. Also, since 2009, EKIF has recommended vaccination against influenza during pregnancy.We conducted this study to assess acceptance and implementation of these recently introduced recommendations. We performed standardized interviews with parents of children born on or after 01.01.2013, hospitalized at the University of Basel Children's Hospital, Switzerland, between January and June 2017. If participation was declined, partial consent was sought for four questions regarding age, education level, attitudes towards vaccinations in general and availability of vaccination records. In 193 of 398 eligible children the mother participated. Five (3%) of 172 mothers had received both pertussis and influenza vaccines during pregnancy, 15 (9%) only against pertussis and 12 (7%) only against influenza. Very few mothers had received vaccination recommendation during pregnancy: 17 (10%) for both pertussis and influenza and 15 (9%) each for pertussis and influenza only. Main reasons for refusal of vaccination despite recommendation were that they were not deemed useful (59% for influenza and 37% for pertussis) and safety concerns for the child (18% for influenza and 26% for pertussis). Recommendation for and immunization rates against pertussis and influenza during pregnancy are low and need to be improved. As recommendations from health care personnel have been shown to have the most significant impact on immunization rates, we propose to focus on improving awareness and acceptance for immunization in pregnancy among health care personnel involved in the care of pregnant women.
Sections du résumé
BACKGROUND
BACKGROUND
Pertussis disease rates are high in Switzerland, especially in infants and young infants. To protect newborns from this serious disease, EKIF, the Swiss National Immunization Technical Advisory Group, has recommended vaccination against pertussis during pregnancy (2nd or 3rd trimester) since 2013. Also, since 2009, EKIF has recommended vaccination against influenza during pregnancy.We conducted this study to assess acceptance and implementation of these recently introduced recommendations.
METHODS
METHODS
We performed standardized interviews with parents of children born on or after 01.01.2013, hospitalized at the University of Basel Children's Hospital, Switzerland, between January and June 2017. If participation was declined, partial consent was sought for four questions regarding age, education level, attitudes towards vaccinations in general and availability of vaccination records.
RESULTS
RESULTS
In 193 of 398 eligible children the mother participated. Five (3%) of 172 mothers had received both pertussis and influenza vaccines during pregnancy, 15 (9%) only against pertussis and 12 (7%) only against influenza. Very few mothers had received vaccination recommendation during pregnancy: 17 (10%) for both pertussis and influenza and 15 (9%) each for pertussis and influenza only. Main reasons for refusal of vaccination despite recommendation were that they were not deemed useful (59% for influenza and 37% for pertussis) and safety concerns for the child (18% for influenza and 26% for pertussis).
CONCLUSIONS
CONCLUSIONS
Recommendation for and immunization rates against pertussis and influenza during pregnancy are low and need to be improved. As recommendations from health care personnel have been shown to have the most significant impact on immunization rates, we propose to focus on improving awareness and acceptance for immunization in pregnancy among health care personnel involved in the care of pregnant women.
Identifiants
pubmed: 31384735
doi: 10.1016/j.jvacx.2019.100013
pii: S2590-1362(19)30014-2
pii: 100013
pmc: PMC6668236
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100013Références
Clin Microbiol Rev. 2005 Apr;18(2):326-82
pubmed: 15831828
Pediatr Infect Dis J. 2007 Apr;26(4):293-9
pubmed: 17414390
Am J Obstet Gynecol. 2009 Dec;201(6):547-52
pubmed: 19850275
Clin Infect Dis. 2010 May 15;50(10):1339-45
pubmed: 20370464
Vaccine. 2011 Mar 3;29(11):2058-65
pubmed: 21251904
Clin Infect Dis. 2011 Jan 15;52(2):157-62
pubmed: 21288837
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S3-8
pubmed: 22920056
Epidemiology. 2012 Nov;23(6):852-60
pubmed: 23018969
Vaccine. 2013 Jan 11;31(4):618-25
pubmed: 23200883
Pediatr Infect Dis J. 2013 Jun;32(6):695-8
pubmed: 23429559
Euro Surveill. 2013 Feb 28;18(9):null
pubmed: 23470020
Hum Vaccin Immunother. 2013 Sep;9(9):1926-31
pubmed: 23782490
BMC Public Health. 2013 Jul 23;13:676
pubmed: 23875762
Pediatr Infect Dis J. 2013 Oct;32(10):1152-4
pubmed: 24067556
Vaccine. 2013 Dec 9;31(51):6087-91
pubmed: 24099874
Pediatr Infect Dis J. 2014 Feb;33(2):147-51
pubmed: 24413406
Swiss Med Wkly. 2014 Apr 29;144:w13955
pubmed: 24782107
JAMA. 2014 May 7;311(17):1760-9
pubmed: 24794369
Am J Obstet Gynecol. 2014 Sep;211(3):299.e1-5
pubmed: 24858200
Prev Med. 2014 Oct;67:316-9
pubmed: 24952094
BMC Infect Dis. 2014 Jul 17;14:397
pubmed: 25037057
Vaccine. 2014 Dec 12;32(52):7057-64
pubmed: 25285883
Vaccine. 2014 Dec 5;32(51):7000-7004
pubmed: 25454869
Vaccine. 2015 Feb 18;33(8):1056-62
pubmed: 25573035
Vaccine. 2015 Apr 27;33(18):2125-31
pubmed: 25796339
Hum Vaccin Immunother. 2015;11(5):1165-72
pubmed: 25874807
Vaccine. 2015 Nov 25;33(47):6469-72
pubmed: 26256526
Vaccine. 2015 Oct 5;33(41):5445-5451
pubmed: 26307234
Obstet Gynecol. 2015 Nov;126(5):1069-74
pubmed: 26444109
BMC Public Health. 2015 Dec 29;16:1308
pubmed: 26965449
Hum Vaccin Immunother. 2016 Apr 2;12(4):879-85
pubmed: 27176822
Hum Vaccin Immunother. 2016 Dec;12(12):3065-3071
pubmed: 27494630
Clin Infect Dis. 2017 Jan 1;64(1):9-14
pubmed: 27624956
Vaccine. 2016 Nov 11;34(47):5785-5791
pubmed: 27742214
Am J Infect Control. 2017 Apr 1;45(4):436-439
pubmed: 28063725
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Obstet Gynecol. 2017 Mar;129(3):560-573
pubmed: 28178054
N Engl J Med. 2017 Mar 30;376(13):1256-1267
pubmed: 28355514
Ann Med. 2018 May;50(3):193-208
pubmed: 29308916
Pediatrics. 2018 Mar;141(3):
pubmed: 29463582
MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1055-1059
pubmed: 30260946